InvestorsHub Logo
Followers 2
Posts 265
Boards Moderated 0
Alias Born 06/27/2016

Re: Amatuer17 post# 98523

Thursday, 03/30/2017 12:24:06 PM

Thursday, March 30, 2017 12:24:06 PM

Post# of 461604
It's clear from all the patent research discussed here over and over and over again that there is no PATENT coverage for treatment of AD once the original 2-73 Greek patent expires in a few years. Yes there is FDA protection but not any other patent protection specifically for AD. When Missling keeps using the same words "There is no patent issue", those were the same exact words he used a nearly 2 years ago when asked about the patent dispute between the company and Dr. V. I think he just keeps throwing that answer out as a way of appearing to give an answer while dodging the intent of the real question. I would be happier if he just said "We do not discuss IP related issues other than to provide a list of approved patents and published applications". Whether he says that or not, that IS the net effect of their current policy. I have emailed them many specific patent questions and all I get back is a list of current approved patents and published applications.
(And now I await someone re-posting that 2015 Melanoma patent # as if it covers AD which it does not)
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News